Corient Private Wealth LP lessened its stake in AptarGroup, Inc. (NYSE:ATR - Free Report) by 31.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 121,044 shares of the industrial products company's stock after selling 55,792 shares during the period. Corient Private Wealth LP owned about 0.19% of AptarGroup worth $15,155,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. State of Wyoming raised its holdings in AptarGroup by 4.5% during the 1st quarter. State of Wyoming now owns 2,252 shares of the industrial products company's stock worth $284,000 after purchasing an additional 98 shares during the last quarter. IFP Advisors Inc increased its position in shares of AptarGroup by 47.0% during the fourth quarter. IFP Advisors Inc now owns 369 shares of the industrial products company's stock worth $45,000 after buying an additional 118 shares during the period. Hanson & Doremus Investment Management increased its position in shares of AptarGroup by 0.7% during the first quarter. Hanson & Doremus Investment Management now owns 17,632 shares of the industrial products company's stock worth $2,222,000 after buying an additional 130 shares during the period. Geneos Wealth Management Inc. raised its stake in AptarGroup by 214.1% during the first quarter. Geneos Wealth Management Inc. now owns 201 shares of the industrial products company's stock worth $25,000 after buying an additional 137 shares during the last quarter. Finally, Rothschild Investment LLC raised its stake in AptarGroup by 231.1% during the fourth quarter. Rothschild Investment LLC now owns 202 shares of the industrial products company's stock worth $25,000 after buying an additional 141 shares during the last quarter. Institutional investors and hedge funds own 88.52% of the company's stock.
Insider Transactions at AptarGroup
In related news, insider Shiela Vinczeller sold 765 shares of the stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $130.37, for a total value of $99,733.05. Following the transaction, the insider directly owned 26,313 shares in the company, valued at $3,430,425.81. This trade represents a 2.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Gael Touya sold 3,740 shares of the stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $133.76, for a total value of $500,262.40. Following the completion of the transaction, the chief executive officer owned 29,102 shares in the company, valued at approximately $3,892,683.52. This represents a 11.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 23,197 shares of company stock worth $3,134,828 in the last three months. Insiders own 0.73% of the company's stock.
Analyst Ratings Changes
A number of brokerages have commented on ATR. Bank of America raised shares of AptarGroup from a "neutral" rating to a "buy" rating and set a $173.00 price target on the stock in a research report on Tuesday, July 14th. Weiss Ratings reissued a "hold (c)" rating on shares of AptarGroup in a research report on Wednesday, June 24th. Wells Fargo & Company boosted their price objective on AptarGroup from $145.00 to $155.00 and gave the company an "overweight" rating in a research note on Monday, August 3rd. Finally, Raymond James Financial restated an "outperform" rating and set a $160.00 target price on shares of AptarGroup in a research report on Wednesday, July 15th. Five equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $172.80.
Get Our Latest Stock Report on ATR
AptarGroup Stock Down 0.2%
AptarGroup stock opened at $124.66 on Wednesday. The company has a market capitalization of $7.93 billion, a PE ratio of 22.54, a PEG ratio of 3.19 and a beta of 0.38. AptarGroup, Inc. has a 12-month low of $103.23 and a 12-month high of $146.91. The firm's fifty day moving average is $130.99 and its 200 day moving average is $126.47. The company has a quick ratio of 1.10, a current ratio of 1.61 and a debt-to-equity ratio of 0.42.
AptarGroup (NYSE:ATR - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The industrial products company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.35 by $0.07. The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.01 billion. AptarGroup had a net margin of 9.22% and a return on equity of 13.31%. The business's quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.66 earnings per share. AptarGroup has set its Q3 2026 guidance at 1.450-1.530 EPS. As a group, sell-side analysts predict that AptarGroup, Inc. will post 5.48 EPS for the current fiscal year.
AptarGroup Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Thursday, August 20th. Investors of record on Thursday, July 30th were paid a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date of this dividend was Thursday, July 30th. AptarGroup's dividend payout ratio is 34.72%.
AptarGroup Company Profile
(
Free Report)
AptarGroup, Inc is a global supplier of dispensing, packaging and drug-delivery solutions. The company develops and manufactures pumps, valves, aerosol systems, closures, dispensing devices and other components used to package and deliver products in the pharmaceutical, beauty, personal care, food and beverage markets.
Its pharmaceutical offerings include nasal, respiratory, ophthalmic and dermal drug-delivery systems, as well as components and technologies designed to support the administration of prescription and consumer healthcare products.
Further Reading
Want to see what other hedge funds are holding ATR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AptarGroup, Inc. (NYSE:ATR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider AptarGroup, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AptarGroup wasn't on the list.
While AptarGroup currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
